Dr. Michael Andrew Grant is a St George, Utah based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. Michael Andrew Grant for Rheumatology is 12812571-1205 in Utah. Dr. Michael Andrew Grant treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Michael Andrew Grant speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Male
Practice Address:
1490 E Foremaster Dr Ste 220, St George, Utah, 84790-4498
Phone:
435-879-7610
Fax:
435-879-7292
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1154851467
NPI Enumeration Date:
19 Jun, 2017
NPI Last Update On:
12 Jul, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Michael Andrew Grant are as mentioned below.
License Number
Specialization
State
Status
12812571-1205
Rheumatologist
Utah
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 912042, Saint George, Utah
Zip:
84791-2042
Phone Number:
435-879-7610
Fax Number:
435-879-7292
Patients can reach Dr. Michael Andrew Grant at 1490 E Foremaster Dr Ste 220, St George, Utah or can call to book an appointment on 435-879-7610. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.